Dyne Therapeutics Inc (DYN)
24.47
+0.50
(+2.09%)
USD |
NASDAQ |
Dec 26, 16:00
26.99
+2.52
(+10.30%)
After-Hours: 04:54
Dyne Therapeutics Cash from Investing (Quarterly): -19.40M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -348.00M |
| Regenxbio Inc | 50.26M |
| Avidity Biosciences Inc | -482.41M |
| Catalyst Pharmaceuticals Inc | -0.259M |
| Sarepta Therapeutics Inc | -128.82M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -74.63M |
| Cash from Financing (Quarterly) | 18.01M |
| Free Cash Flow | -244.42M |
| Free Cash Flow Per Share (Quarterly) | -0.7423 |
| Free Cash Flow Yield | -11.90% |